IPS - Clinisol
Biological
Baxter Healthcare
Total Payments
$154,580
Transactions
8
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $18,785 | 3 | 2 |
| 2021 | $16,795 | 1 | 0 |
| 2020 | $33,000 | 1 | 0 |
| 2019 | $53,000 | 2 | 0 |
| 2018 | $33,000 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $154,451 | 6 | 99.9% |
| Food and Beverage | $129.26 | 2 | 0.1% |
Payments by Type
Research
$154,451
6 transactions
General
$129.26
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Randomized Controlled Trial of a Combined Nutrition -Protein Supplementation- and EXercISe Intervention in Mechanically Ventilated Critically Ill Patients -the NEXIS trial- | Baxter Healthcare | $86,000 | 0 |
| A Randomized Controlled Trial of a Combined Nutrition -Protein Supplementation- and EXercISe Intervention in Mechanically Ventilated Critically Ill Patients the NEXIS trial | Baxter Healthcare | $33,000 | 0 |
| Combined Intraveneous Protein | Baxter Healthcare | $18,656 | 0 |
| A Randomized Controlled Trial of a Combined Nutrition (Protein Supplementation) and Exercise Intervention in Mechanically Ventilated Critically Ill Patients the NEXIS trial | Baxter Healthcare | $16,795 | 0 |
Ad
Manufacturing Companies
- Baxter Healthcare $154,580
Product Information
- Type Biological
- Total Payments $154,580
- Total Doctors 2
- Transactions 8
About IPS - Clinisol
IPS - Clinisol is a biological associated with $154,580 in payments to 2 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is Baxter Healthcare.
Payment data is available from 2018 to 2024. In 2024, $18,785 was paid across 3 transactions to 2 doctors.
The most common payment nature for IPS - Clinisol is "Unspecified" ($154,451, 99.9% of total).
IPS - Clinisol is associated with 4 research studies, including "A Randomized Controlled Trial of a Combined Nutrition -Protein Supplementation- and EXercISe Intervention in Mechanically Ventilated Critically Ill Patients -the NEXIS trial-" ($86,000).